ArticleNature communications2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis.
Mattheus H E Wildschut et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it